Cargando…

Research status on immunotherapy trials of gastric cancer

The breakthrough of immune checkpoint inhibitor (ICI) therapy has created extensive opportunities for cancer immunotherapy. Especially, the block of programmed death-1/programmed death ligand 1 (PD-L1) axis using ICIs has become a new therapeutic strategy to treat advanced gastric cancer (GC). Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Chao, Wu, Heng-Miao, Yu, Wei-Ming, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316931/ https://www.ncbi.nlm.nih.gov/pubmed/34368297 http://dx.doi.org/10.12998/wjcc.v9.i21.5782

Ejemplares similares

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023)

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019)

Progress in the research of cuproptosis and possible targets for cancer therapy
por: Wang, Jiang, et al.
Publicado: (2023)

Evaluation of polygenic risk score for risk prediction of gastric cancer
por: Wang, Xiao-Yu, et al.
Publicado: (2023)

Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021)

Artificial intelligence in gastric cancer: Application and future perspectives
por: Niu, Peng-Hui, et al.
Publicado: (2020)

Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
por: Pan, Wei-Xuan, et al.
Publicado: (2023)

Effect of oncometabolic surgery on gastric cancer: The remission of hypertension, type 2 diabetes mellitus, and beyond
por: Cheng, Yu-Xi, et al.
Publicado: (2021)

The impact of socioeconomic status on access to cancer clinical trials
por: Sharrocks, K, et al.
Publicado: (2014)

Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines
por: Wang, Xian-Ze, et al.
Publicado: (2020)

Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer
por: Ye, Hui-Nan, et al.
Publicado: (2023)

Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004)

Gastric per-oral endoscopic myotomy: Current status and future directions
por: Podboy, Alexander, et al.
Publicado: (2019)

Treatment strategies for gastric cancer during the COVID-19 pandemic
por: Kang, Wen-Zhe, et al.
Publicado: (2020)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
por: Guo, Songchuan, et al.
Publicado: (2017)

T-regulatory cell modulation: the future of cancer immunotherapy?
por: Nizar, S, et al.
Publicado: (2009)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Status, challenges, and future prospects of stem cell therapy in pelvic floor disorders
por: Cheng, Juan, et al.
Publicado: (2020)

Endoscopic advances in the management of gastric cancer and premalignant gastric conditions
por: Park, Erica, et al.
Publicado: (2023)

iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
por: Karagiannis, Peter, et al.
Publicado: (2021)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019)

Exploring the food-gut axis in immunotherapy response of cancer patients
por: Russo, Edda, et al.
Publicado: (2020)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Overgrowth of Lactobacillus in gastric cancer
por: Li, Zhi-Peng, et al.
Publicado: (2021)

Tumor budding in gastric cancer
por: Xiao, Shuo-Meng, et al.
Publicado: (2023)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
por: Xu, Jun-Xi, et al.
Publicado: (2021)

Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018)

Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
por: Remon, Jordi, et al.
Publicado: (2017)

Examined lymph node count for gastric cancer patients after curative surgery
por: Zeng, Yi, et al.
Publicado: (2023)

Development and future perspectives of natural orifice specimen extraction surgery for gastric cancer
por: Zhang, Zhi-Cao, et al.
Publicado: (2022)

Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
por: Tintelnot, Joseph, et al.
Publicado: (2019)

Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
por: Xu, Yi-Han, et al.
Publicado: (2022)

From basic to clinical: Anatomy of Denonvilliers’ fascia and its application in laparoscopic radical resection of rectal cancer
por: Chen, Zhou, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e31pe81imv4tsepndpnqiikmdl